<DOC>
	<DOCNO>NCT02217852</DOCNO>
	<brief_summary>Several survey reveal Tibetan adult high prevalence hypertension . However , research study antihypertensive effect know drug Tibetan . The main arm study determine efficacy low blood pressure protect target organ damage differs nitrendipine Hydrochlorothiazide mild hypertension Tibetan , determine efficacy low blood pressure protect target organ damage differs captopril plus Hydrochlorothiazide Beijing hypotensive No.0 moderate severe Tibetan hypertension .</brief_summary>
	<brief_title>Treatment Hypertension Tibetan Adult Population</brief_title>
	<detailed_description>Several survey reveal Tibetan adult high blood pressure ( BP ) prevalence hypertension part China also high develop nation well . For example , one study find among Tibetan herdsman 40 year old , prevalence hypertension 56 % mean systolic blood pressure/diastolic blood pressure 146.6/92.0mmHg . However , rate awareness , treatment , control dismally low . The Tibetan living Tibetan Plateau . The special natural social environment there，as well ethnic , may involve etiology high prevalence effect response antihypertensive treatment . Nevertheless , interventional study do Tibetan hypertensive patient . Therefore , purpose study compare blood pressure reduction different antihypertensive drug . Nitrendipine , hydrochlorothiazide , captopril Beijing hypotensive No.0 ( also name '' compound hypotensive tablet '' ) select , cheap available Tibetan Plateau . Nitrendipine , hydrochlorothiazide captopril representative Dihydropyridines Calcium antagonist , diuretic , angiotensin-converting enzyme inhibitor , respectively . They recommend first-line antihypertensive drug . Beijing hypotensive No.0 produce China Resources Double-crane Pharmaceutical company China , fixed-dose combination contain reserpine 0.1mg , hydrochlorothiazide 12.5mg , dihydralazine sulfate 12.5mg , triamterene 12.5mg . Many study conduct China demonstrate efficacy safety low blood pressure . After recruitment , participant group accord BP . If BP＜160/100mmHg , monotherapy start . Patient randomly assign receive nitrendipine 10mg bid Hydrochlorothiazide 12.5mg qd . If BP≥160/100mmHg , Patient randomly assign receive two drug combination therapy ( captopril 25mg three time daily ( tid ) Hydrochlorothiazide 12.5mg qd ) Beijing hypotensive No.0 one pile qd . During follow 12 months，each participant take least four visit 1、3、6 12 month respectively . Goal BP participant less 140/90mmHg , achieve titrating assign study drug add open-label agent necessary . The maximum dosage 20mg BID nitrendipine , 25mg qd Hydrochlorothiazide 50mg tid captopril . The dosage Beijing hypotensive No.0 add .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Captopril</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Nitrendipine</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>1 . Adult Tibetan , live Tibetan Plateau since he/she bear . 2 . Consistent diagnose hypertension , blood pressure , 13 grade . 3 . Aged 1880 year old . 4 . To sign informed consent . 1. diagnosis secondary hypertension 2 . Hypertensive emergency urgencies 3 . Malignant hypertension 4 . Bilateral renal artery stenosis , Chronic Kidney Disease（CKD） , serum creatinine &gt; 133μmol / L. 5 . Suffering congenital heart disease , rheumatic heart disease , hypertrophic cardiomyopathy , aortic stenosis . 6 . Occurred within past 6 month stroke transient ischemic attack ( TIA ) , unstable angina , myocardial infarction , percutaneous transluminal coronary angioplasty ( PTCA ) . 7. clinical significance arrhythmia 8 . Active liver disease , history chronic persistent hepatitis , alanine aminotransferase（ALT） &gt; upper limit normal . 9 . Pregnancy , pregnancy breastfeed woman prepare .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>hypertension</keyword>
	<keyword>Tibetan</keyword>
	<keyword>Nitrendipine</keyword>
	<keyword>hydrochlorothiazide</keyword>
	<keyword>captopril</keyword>
	<keyword>Beijing hypotensive No.0</keyword>
</DOC>